Companies Related to "Prevalence Hypothyroidism Nonalcoholic Fatty Liver Disease" [Most Relevant Company Matches] RSS

20:19 EDT 25th October 2014 | BioPortfolio

Here are the most relevant search results for "Prevalence Hypothyroidism Nonalcoholic Fatty Liver Disease" found in our extensive corporate database of over 50,000 company records.

Showing "Prevalence Hypothyroidism Nonalcoholic Fatty Liver Disease" Companies 1–25 of 2,200+

Extremely Relevant

American Liver Foundation

The American Liver Foundation is the nation’s largest non-profit organization focused solely on promoting liver health and disease prevention. The mission of the American Liver Foundation is to facilitate, advocate and promote education, support and research for the prevention, treatment and cure of liver disease.

Relevant

Vesta Therapeutics, Inc

Vesta Therapeutics is a privately held company developing cell therapeutics for liver repair and regeneration. The Company's technology is centered on the isolation, expansion, and cryopreservation of liver cells (human hepatocytes) obtained from organ donor livers that are not suitable for whole organ transplantation. Clinicians in academic settings have found that, following administration, huma...

AlphaNet, Inc.

Alpha-1 Antitrypsin Deficiency is one of North America’s most prevalent, potentially lethal hereditary disorders. Discovered in 1963, Alpha-1 can cause life-threatening lung and/or liver disease. It is a leading genetic killer of adults in North America and a leading cause of liver transplants in children. It is estimated that between 10,000 and 15,000 ...

AlphaNet

Alpha-1 Antitrypsin Deficiency is a leading genetic killer of adults and a leading cause of liver transplants in children. It is estimated that 20 million Americans are undetected carriers of the Alpha-1 gene and may be at risk for lung and/or liver disease. Only 10 percent of the estimated 100,000 with severe deficiency of Alpha-1 have been diagnosed.

ORIDIS Biomed GmbH

ORIDIS™ Biomed is a biomedical company focusing on the discovery and development of therapeutics and targeted treatment solutions for liver cancer and metabolic diseases of the liver.ORIDIS™ Biomed has built a potent drug discovery and development organization based on its extensive scientific and clinical expertise in the area of liver disease, its proprietary TISSOMICS™ research engine, an...

Pathway Medical Technologies Inc.

Pathway Medical Technologies, Inc. (Pathway), located in Redmond, Washington was founded in 1998 to design, develop and manufacture innovative medical devices intended for the treatment of arterial disease. The company’s initial focus is on peripheral artery disease (PAD).According to the American Heart Association, peripheral artery disease affects 8 – 12 million in the U.S. PAD prevalence in...

iQur Ltd

iQur® is a specialty pharmaceutical company at the forefront of international breakthroughs in the detection, treatment and monitoring of Hepatitis C and other liver diseases.iQur exists to provide clinicians with a comprehensive, 24–48 hour service for genotyping, qualitation and quantification of both the Hepatitis C (HCV) and Hepatitis B (HBV) viruses.Founded in 2003 by liver disease special...

Efamol ltd

Efamol specialises in essential fatty acid (EFAs) based products, the so called "good fats" that are essential for the healthy functioning of every cell in the human body. These "good fats" are from the Omega-3 and Omega-6 families of nutrients and are sourced from high quality fish oils and evening primrose oil. Since it's inception Efamol has developed a specialised range of fatty acid based pro...

Incara Pharmaceuticals

Incara Pharmaceuticals Corporation focuses on the protection and regeneration of tissue damaged by injury and disease. The company currently has programs in three areas: liver cell therapy and progenitor cell therapy as a treatment for liver failure; small molecule catalytic antioxidants as treatment for stroke and tissue damage; and deligioparin (formerly named OP2000), an ultra-low molecular wei...

YES

YES is a grassroots organization that provides cancer patients with support, resources, options, education and hope in their fight against liver tumors. It is made up of survivors who have undergone treatment for primary hepatocellular (liver) cancer or liver metastases (cancer that has spread to the liver) from other cancers. For more information ...

Galectin Therapeutics, Inc.

Galectin Therapeutics (OTC: GALT) is developing promising carbohydrate-based therapies for fibrotic liver disease and cancer based on the Company’s unique understanding of galectin proteins, key mediators of biologic function. We are leveraging extensive scientific and development expertise as well as established relationships with external sources to...

The Global Genes Project

The Global Genes Project is a campaign of the Children's Rare Disease Network and is a grassroots effort with the goal to increase awareness about the prevalence of rare diseases worldwide. The Children's Rare Disease Network is a registered 501c3 non profit organization. For more information, visit http://www.crdnetwork.org.

Arbios Systems, Inc.

Arbios Systems, Inc. is developing proprietary medical devices and cell-based therapies to enhance the survival of millions of patients each year who experience, or are at risk for, life-threatening episodes of liver failure. The Arbios product candidate portfolio includes the SEPET™ Liver Assist Device, a novel blood purification therapy that provides enhanced “liver dialysis,” and the H...

Exalenz Bioscience, Inc.

Exalenz Bioscience develops and markets medical equipment for breath testing for the purposes of diagnosis and management of digestive system and liver conditions. The company sells the BreathID® System together with proprietary disposable test kits. The BreathID® System has been proven effective for clinical use in the task of identifying the presen...

The Pelican Cancer Foundation

The Pelican Cancer Foundation is a unique charity, dedicated exclusively to curing cancer patients by advancing the latest techniques of precision surgery.The Charity derives its name from the words Pelvic and Liver Cancer.Formed in 2000, it was based around the pioneering work ofProfessor ‘Bill’ Heald OBE, Mr Brendan Moran and colleagues at the North Hampshire Hospital in bowel cancer surgery...

Esperion

We discover and develop pharmaceutical products for the treatment of cardiovascular disease, which is disease of the heart and the body's blood vessels and related organs. We intend to commercialize a novel class of drugs that focus on a new treatment approach we call "HDL Therapy," which is based on our understanding of high density lipoprotein, or HDL, function. HDL is the primary facilitator of...

MS Central Support

Multiple Sclerosis a life-long chronic disease. Multiple Sclerosis signifies the following: "Multiple" refers to the many areas of inflammation and demyelination that occurs over time. "Sclerosis" means scarring. MS is an autoimmune disease. In MS, the immune system attacks the body's myelin. Myelin is a fatty protein that acts as an insulating matter for nerves. When myelin becomes damaged (demye...

Amphioxus Cell Technologies

Amphioxus Cell Technologies is a biotechnology company based in Houston, Texas.The Company was founded by James Kelly and Norman Sussman to develop human liver based ADME/Tox tools. Our ACTIVTox® product achieves this goal by combining a highly developed human liver cell line with meaningful, high throughput assays.

HµREL Corporation

HµREL Corporation is a development-stage enterprise based in Beverly Hills, California. HµREL’s development is proceeding under the aegis of Athena Capital Partners, LLC, a Los Angeles enterprise sponsorship firm (www.athenacapital.net). HµREL is presently inaugurating a Joint Scientific Collaboration (“JSC”), through which a group of global pharmaceutical and consumer products firms will...

DeveloGen AG

DeveloGen is a leading biotechnology company developing innovative gene-based medicines. By applying novel functional genomic and gene discovery techniques to developmental biology, DeveloGen has pioneered programs in diabetes, obesity and liver regeneration. In 1999, DeveloGen and its founders were awarded the German President's prize for innovation. In May 2000, DeveloGen merged with HepaVec AG ...

Diacrin Incorporated

Diacrin is developing transplantable cells for the treatment of human diseases which are characterized by cell dysfunction or cell death and for which current therapies are either inadequate or nonexistent. Products under development for the treatment of neurological disorders include: NeuroCell(TM)-PD for Parkinson's disease and NeuroCell(TM)-HD for Huntington's dise...

Incara Pharmaceuticals Corporation

Incara Pharmaceuticals Corporation conducts discovery and development programs in three areas: (1) inflammatory bowel disease, using an ultra-low molecular weight heparin; (2) liver disorders, using a novel form of hepatic progenitor cell therapy; and (3) novel small molecule antioxidants for disorders such as stroke, asthma and reperfusion injury.

Cytonet GmbH & Co. KG

"Cytonet provides successful solutions to heal life-threatening diseases by using pharmaceuticals based on human cells while using the competence in cell-therapy to extend the world-wide leading position in in vitro and in vivo therapy of heaviest disease of vital parts, especially the liver."

Heart Research Institute Ltd

The Heart Research Institute Ltd (HRI) was established in 1989 through a joint initiative of the National Heart Foundation of Australia, the Cardiologists of Royal Prince Alfred Hospital and the New South Wales and Federal governments. As an independent world-class research institute, HRI is a centre for scientific excellence with a focus on researching and understanding the origins and mechanisms...

Hepregen Corporation

Hepregen Corporation is the undisputed leader in innovating unique and proprietary bioengineered micro- liver platforms for use in environmental testing, preventive care, and pharmaceutical, biotherapeutic and diagnostic product development. The Company’s “liver-in-a-dish” HepatoPac™ and HepatoMune™ products support a potential par...


More From BioPortfolio on "Prevalence Hypothyroidism Nonalcoholic Fatty Liver Disease"

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks